A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
Clinical trial NCT01243268 · COMPLETED
Trial details
- NCT number
- NCT01243268
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-12-21
- Primary completion
- 2016-06-27
- Enrollment
- 674
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.